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Abstract: Krebs cycle intermediates (KCIs) are reported to function as energy substrates in
mitochondria and to exert antioxidants effects on the brain. The present study was designed to
identify which KCIs are effective neuroprotective compounds against oxidative stress in neuronal
cells. Here we found that pyruvate, oxaloacetate, and α-ketoglutarate, but not lactate, citrate,
iso-citrate, succinate, fumarate, or malate, protected HT22 cells against hydrogen peroxide-mediated
toxicity. These three intermediates reduced the production of hydrogen peroxide-activated reactive
oxygen species, measured in terms of 2′,7′-dichlorofluorescein diacetate fluorescence. In contrast,
none of the KCIs—used at 1 mM—protected against cell death induced by high concentrations of
glutamate—another type of oxidative stress-induced neuronal cell death. Because these protective
KCIs did not have any toxic effects (at least up to 10 mM), they have potential use for therapeutic
intervention against chronic neurodegenerative diseases.
Keywords: oxaloacetic acid; alpha-ketoglutaric acid; pyruvic acid; reactive oxygen species; neuron
1. Introduction
The Krebs cycle is a series of enzymatic reactions that catalyze the aerobic metabolism of fuel
molecules to carbon dioxide and water, thereby generating energy for the production of adenosine
triphosphate molecules. Many types of fuel molecules can be drawn into and utilized by the cycle,
including acetyl coenzyme A, derived from glycolysis or fatty acid oxidation. In eukaryotic cells, most
of the enzymes catalyzing the reactions of the Krebs cycle are found in the mitochondrial matrixes [1].
The compounds involved in the cycle—termed Krebs cycle intermediates (KCIs)—function as energy
donors and precursors for the synthesis of amino acids, lipids, and carbohydrates [2].
This aerobic metabolism may pervade every aspect of biology and medicine, because many
papers published within the last 10 years suggest that KCIs regulate epigenetic processes and cellular
signaling, possibly via protein binding [3]. KCIs activate specific signaling transduction pathways
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and exert various biological actions, such as neuroprotection, anti-inflammation, osteogenesis, and
anti-aging [3]. For example, external supplementation with pyruvate (PA), oxaloacetate (OAA),
α-ketoglutarate (AKG), malic acid (MA) or fumarate (FA), but not lactic acid (LA), succinate (SA),
citrate (CA) or iso-citrate (ICA) significantly extends the lifespan of Caenorhabditis elegans by activating
various transcriptional factor(s)-dependent transcriptional pathways [4–6]. Although fragmental
information about the physiological roles of KCIs in the brain is available, KCIs are also proposed as
being cardioprotective agents against myocardical infarction [7]. FA and AKG have been proposed
to protect cardiac muscles possibly through activating or inhibiting specific transcription factors,
such as NF-E2 related factor 2 (NRF2) and hypoxia inducible factor (HIF-1), respectively. In neurons,
PA prevents hydrogen peroxide (H2O2)-induced cell death [8,9], protects the brain against experimental
stroke via an anti-inflammatory mechanism [10], and prevents the age-dependent cognitive deficits
seen in a mouse model of Alzheimer’s disease [11]. These protections are possibly due to its α-ketoacid
structure, which can directly react with H2O2 [8,9].
H2O2 is a stable, uncharged, and freely diffusible reactive oxygen species (ROS) with a putative
second messenger role in intracellular and extracellular signaling mechanisms [12]. The generation of
H2O2 is relatively high in the brain, partly because of the high activities of oxygen consumption and
partly because of the high level of expression of monoamine oxidase in this tissue [13]. In pathological
conditions such as ischemia–reperfusion and Alzheimer’s disease, various cell types may produce
large amounts of H2O2 [13]. In addition to enzymatic defense mainly mediated by various enzymes
(i.e., glutathione (GSH) peroxidase, catalase, and peroxiredoxins), non-enzymatic mechanisms can
also contribute to the cellular defense against H2O2-induced cytotoxicity [13]. For instance, PA is
abundant in mammalian cells and has the property of non-enzymatically reacting with H2O2 [8,9].
PA protects neurons against both exogenous and endogenous H2O2, and it also inhibits cell death
mediated by H2O2 in neurons [8] and non-neuronal cells [9]. However, whether KCIs other than PA,
OAA, and AKG really elicit neuroprotection through a simple direct interaction with exogenous H2O2
at extracellular locations has not yet been fully clarified.
In this present study, we examined the neuroprotective effects of KCIs against two types of
oxidative stress in neuronal HT22 cells and found that only three of them (PA, OAA, and AKG)—which
have an α-keto acid structure—had significant neuroprotective effects by modulating the levels of ROS
in the cells. We found that the other KCIs were not protective, suggesting that these neuroprotective
KCIs—used singly or as a cocktail—could be a potential food supplement for the purpose of preventing
chronic neurodegeneration.
2. Materials and Methods
2.1. Chemicals
All KCIs (sodium salt), sodium glutamate (Glu), hydrogen peroxide (H2O2), and
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) were purchased from Wako
Junyaku (Tokyo, Japan). Stock solutions of KCIs (100 or 1000 mM) were prepared in Ca2+, Mg2+-free
phosphate-buffered saline (PBS(-), Invitrogen, Carlsbad, CA, USA). 2′,7′-Dichlorodihydrofluorescin
diacetate (DCFH-DA, Sigma-Aldrich, St. Louis, MO, USA) stock solution was prepared in 10 mM
dimethyl sulfoxide solution and used at 10 µM in the culture medium.
2.2. HT22 Cultures and MTT Assay
HT22 hippocampal neuronal cells were cultured as described previously [14–16]. In HT22 cells,
high concentrations (mM levels) of Glu can induce cell death by depleting intracellular GSH through
inhibition of cystine influx, and relatively low concentrations (µM levels) of H2O2 can induce cell
death. Because HT22 cells do not have functional NMDA receptor proteins, they do not die due to
excitotoxicity [14–16]. These cells were maintained in 10-cm dishes (Invitrogen, Carlsbad, CA, USA)
containing 10 mL of Dulbecco’s Modified Eagle medium supplemented with 10% (v/v) heat-inactivated
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(56 ◦C, 30 min) fetal calf serum (Invitrogen). The cells were seeded into 24-well plates at a density
of 4 × 104 cells/cm2. When examining their effects on the H2O2 toxicity, we added KCIs to the
cultures after a 24-h incubation. Sixty minutes later, 100, 200, or 500 µM H2O2 was added, and the
cells were then incubated for an additional 24 h. We set differential pre-incubation time 24 h and
1 h for Glu- and H2O2-toxicity, respectively. This was to stabilize the response to H2O2, and also
because the Glu toxicity is completely inhibited by the long preincubation (over 5 h) by an unknown
mechanism [14–16]. When the effects of KCIs on oxidative Glu toxicity were examined, the cells were
incubated for 1 h after having been seeded in wells of a 24-well plate, and the KCIs were then added to
the cultures. Sixty minutes later, 5, 10, or 20 mM Glu was added, and the cells were then incubated for
an additional 24 h. To evaluate survival of the HT22 cells, we performed the MTT assay [14–16].
2.3. DCF Assay
The extent of cellular oxidative stress was assessed by monitoring the formation of free-radical
species by using DCFH-DA, as described elsewhere [17]. Cells were plated 24 h before initiation of
the experiment at a density of 40,000 cells/well in 24-well plates. KCIs and 10 µM DCFH-DA were
added to the cells 30 min before the measurement. The plate was set into a Spark10M (Tecan Japan,
Tokyo, Japan) under an atmosphere of 5% CO2 and temperature of 37 ◦C. H2O2 (200 µM) or vehicle
was added to wells at 30 min, and the cells were incubated further for 180 min. DCF fluorescence was
measured at a 485-nm excitation wavelength and 538-nm emission wavelength at 10-min intervals.
Fluorescence values were expressed as a percentage of the value for the untreated control.
2.4. Statistical Analysis
Experiments presented herein were repeated at least three times, with each experiment performed
in quadruplicate. Data were presented as the mean ± SD. The statistical significance of differences
was examined by performing Student’s t-test.
3. Results
3.1. Neuroprotective Effect of PA, OAA, and AKG on HT22 Cells
We used HT22 cells—a neuronal cell line derived from a mouse hippocampus—as a model for
oxidative cell damage. Treatment of the cells with 100, 200, or 500 µM H2O2 (Figure 1A) or with 5, 10,
or 20 mM Glu (Figure 1B) induced cell death by oxidative stress within 24 h. Pre (1 h)-treatment of the
cells with the KCIs at 1 mM protected the cells from the toxic effects of H2O2 (Figure 1A), whereas these
KCIs were not—or very little if they were—protective against Glu toxicity (Figure 1B). These KCIs
were not toxic to HT22 cells up to 10 mM, but they caused a small but significant reduction in cell
survival when used at 20–50 mM (Figure 2). These results suggest that PA, OAA, and AKG could
protect neuronal cells against H2O2, but not against Glu.
3.2. Regulation of ROS by PA, OAA, and AKG
As the neuroprotective effects of the KCIs may have been due to the chemical structure of α-keto
acid by direct interaction with H2O2 inside the cells, we next examined whether the KCIs could reduce
the level of ROS in HT22 cells (Figure 3). We quantified the levels of ROS with the ROS-sensitive
fluorescent indicator DCFH-DA by use of a Spark 10M device (Tecan Japan, Tokyo, Japan). Based
on the fluorescence activity, H2O2 (200 µM) increased the levels of ROS by 20–40-fold. ROS levels
plateaued at 45–60 min of exposure. PA (Figure 3A) or OAA (Figure 3B) at 1, 2, or 10 mM, and 2 or
10 mM AKG (Figure 3C) significantly lowered intracellular ROS formation; 1 mM AKG did not reduce
the ROS level. These results suggest that these KCIs used at low mM levels effectively reduced the
ROS level in neural cells.
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Figure 1. Protection of HT22 against (A) H2O2 and (B) Glu by pyruvate (PA), oxaloacetate (OAA), and 
α-ketoglutarate (AKG). (A) Protective effects of 1mM PA, OAA, or AKG against various 
concentrations of H2O2. (B) No protective effect of 1 mM PA, OAA, or AKG against high 
concentrations of Glu was found. White bars indicate H2O2 or Glu alone; and gray bars H2O2 + KCI 
(PA, OAA, or AKG). Values, presented as a percentage of the control MTT (3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyl tetrazolium bromide) value (obtained in the absence of glutamate), are given as the mean 
± SD (n = 4). * significantly different (p < 0.05) from samples without a KCI. KCI: Krebs cycle intermediate. 
 
Figure 2. Toxic effects of KCIs by themselves. PA, OAA, AKG, succinate (SA), lactic acid (LA), 
fumarate (FA), and malic acid (MA) did not reduce cell survival up to 10 mM, whereas citrate (CA) 
and iso-citrate (ICA) reduced it when used at concentrations around 5–10 mM. Values, presented as 
Figure 1. Protection of HT22 against (A) H2O2 and (B) Glu by pyruvate (PA), oxaloacetate (OAA), and
α-ketoglutarate (AKG). (A) Protective effects of 1mM PA, OAA, or AKG against various concentrations
of H2O2. (B) No protective effect of 1 mM PA, OAA, or AKG against high concentrations of Glu was
found. White bars indicate H2O2 or Glu alone; and gray bars H2O2 + KCI (PA, OAA, or AKG). Values,
presented as a percent ge of the control MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl t trazolium
bromide) value (obtained in the absence of gluta ate), are given as the mean± SD (n = 4). * significantly
different (p < 0.05) from samples without a KCI. KCI: Krebs cycle intermediate.
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Figure 2. Toxic effects of KCIs by themselves. PA, OAA, AKG, succinate (SA), lactic acid (LA), fumarate
(FA), and malic acid (MA) did not reduce cell survival up to 10 mM, whereas citrate (CA) and iso-citrate
(ICA) reduced it when used at concentrations around 5–10 mM. Values, presented as a percentage
of the control MTT value (obtained in the absence of glutamate), are given as the mean ± SD (n = 4).
* significantly different (p < 0.05) from samples without a KCI.
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Figure 3. Modulation of reactive oxygen species (ROS) level by (A) PA, (B) OAA, or (C) AKG against 
H2O2-induced cytotoxicity. The measurement of the cells loaded with 10 μM DCFH-DA  
(2′,7′-Dichlorodihydrofluorescin diacetate) for 30 min started at 0 min, and DCF fluorescence levels 
are shown at 10-min intervals. Various concentrations (1, 2, and 10 mM) of PA, OAA, or AKG were 
added to the cultures at the same time as DCFH-DA addition. H2O2 (200 μM) was added at 30 min. 
Values are the means ± SD from four experiments per group. Diamonds, control; circles, H2O2; 
squares, H2O2 + KCI. Note that the KCI alone groups were not shown in these graphs, because KCIs 
themselves did not affect ROS levels at any time point.  
3.3. No Protective Effects by LA, CA, ICA, SA, FA, and MA against H2O2 
Next, we assessed whether LA, CA, ICA, SA, FA, and MA could protect HT22 cells against H2O2, 
and found that these intermediates were not—or were very little if they were—protective against 
H2O2 (100, 200, and 500 μM)-mediated cytotoxicity (Figure 4). Then, we examined whether these KCIs 
could protect the cells against Glu toxicity. Additionally, except for SA against 5 mM Glu, these KCIs 
Figure 3. Modulation of reactive oxygen species (ROS) level by (A) PA, (B) OAA, or (C) AKG
against H2O2-induced cytotoxicity. The measurement of the cells loaded with 10 µM -
(2′,7′- ic l r i r fl rescin diacetate) for 30 min started at 0 min, and DCF fluorescence levels are
shown at 10-min intervals. Various c ncentrations (1, 2, and 10 mM) of PA, OA , or AKG were added
to the cultures at th s me time as DCFH- A addition. H2O2 (200 µM) was added t 30 min. Values
are the m ans ± SD from fou experiments per grou . Diamonds, control; circles, H2O2; quares,
H2O2 + KCI. Note that the KCI alone groups we e not shown in these graphs, b cause KCIs themselve
did not affect ROS levels at any time point.
3.3. o Protective Effects by LA, CA, ICA, SA, FA, and A against 2 2
ext, e assessed hether L , C , IC , S , F , and could protect T22 cells against 2 2,
and found that these inter ediates ere not or ere very little if they ere protective against
2 2 (100, 200, and 500 µM)-mediated cytotoxicity (Figure 4). Then, we examined whether these
KCIs could protect the cells against Glu toxicity. Additionally, except for SA against 5 mM Glu, these
KCIs (at 1 mM) showed no protection against high concentrations (5, 10, and 20 mM) of Glu (Figure 5).
These results indicate that LA, CA, ICA, SA, FA, and MA could not protect HT22 cells against oxidative
stress. LA, SA, FA, and MA were not toxic to the cells up to 10 mM. By some unknown mechanism,
CA and ICA gave toxic effects when tested around 5–10 mM (Figure 2). A high concentration of FA
had an exceptional action on the cells, because 10 mM FA gave significant protection against high
concentrations of Glu (Figure 5).
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Figure 4. No protection of HT22 cells against H2O2 by the other KCIs at 1 mM. Neither LA, CA, ICA,
SA, FA, nor MA protected the cells against H2O2-mediated cytotoxicity. White bars are H2O2 alone;
and gray bars are H2O2 + KCI. Values, presented as a percentage of the control MTT value (obtained in
the absence of glutam te), are given as the mean ± SD (n = 4). * significantly different (p < 0.05) from
samples without a KCI.Antioxidants 2017, 6, 21 7 of 10 
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AKG could be due to an H2O2-scavenging effect of them inside the cells. The conclusion of this study 
is illustrated in Figure 6A and B. PA, OAA, and AKG were neuroprotective, but not the other KCIs. 
For example, LA and MA— putative neuronal energy substrates that may produce protective KCIs 
through their metabolism [1,2]—did not protect the cells (Figures 4 and 5). AKG may have other 
protective effects than α-keto acids such as PA and OAA. AKG at 1mM protected the cells against 
H2O2 (Figure 1) without causing a significant reduction in ROS levels (Figure 3). Because AKG is 
reported to activate the degradation of HIF-1α subunit and reduce the expression of downstream 
enzymes [6,7], reduction of this pathway may have been involved in the protective effects of AKG. 
FA may be another exceptional KCI. FA at 10 mM protected the cells against Glu-mediated 
cytotoxicity (Figure 5), although the other KCIs did not do so. Because FA is reported to activate the 
Nrf2 pathway and induce phase-2 enzymes [18], the activation of this pathway may have been 
involved in the FA-induced protection. 
Interestingly, the protection afforded by PA, OAA, and AKG was totally different than that of 
NRF2 activators such as carnosic acid [19,20], zonarol [21,22], and tert-butyl hydroquinone [23]. These 
activators can protect cells against a high concentration of Glu, but not against H2O2. Nrf2 activators 
Figure 5. No protection of HT22 cells against Glu by the other KCIs at 1 mM. Neither LA, CA, ICA, SA,
nor MA protected the cells against Glu used at 1 or 10 mM. FA at 10 mM protected the cells against
Glu, although 1 mM FA did not. White bars indicate Glu alone, and gray bars Glu + KCI. Values,
presented as a percentage of the control MTT value (obtained in the absence of glutamate), are given as
the mean + SD (n = 4). * significantly different (p < 0.05) from samples without a KCI.
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4. Discussion
Here, we found that the α-keto acid group-containing KCIs (PA, OAA, and AKG) could protect
neurons against H2O2, possibly through direct interaction with H2O2, although we did not provide
direct evidence for this chemical reaction itself. Because DCFH-DA is hydrolyzed by cytosolic esterase
and is activated by ROS in the cytoplasm, the inhibition of ROS increase by PA, OAA, and AKG
could be due to an H2O2-scavenging effect of them inside the cells. The conclusion of this study is
illustrated in Figure 6A and B. PA, OAA, and AKG were neuroprotective, but not the other KCIs.
For example, LA and MA— putative neuronal energy substrates that may produce protective KCIs
through their metabolism [1,2]—did not protect the cells (Figures 4 and 5). AKG may have other
protective effects than α-keto acids such as PA and OAA. AKG at 1mM protected the cells against
H2O2 (Figure 1) without causing a significant reduction in ROS levels (Figure 3). Because AKG is
reported to activate the degradation of HIF-1α subunit and reduce the expression of downstream
enzymes [6,7], reduction of this pathway may have been involved in the protective effects of AKG.
FA may be another exceptional KCI. FA at 10 mM protected the cells against Glu-mediated cytotoxicity
(Figure 5), although the other KCIs did not do so. Because FA is reported to activate the Nrf2 pathway
and induce phase-2 enzymes [18], the activation of this pathway may have been involved in the
FA-induced protection.
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protect cells against high Glu concentrations by inhibiting the decrease in GSH by induction of Phase-
2 enzymes, the action of which enhances the production of GSH [24–26]. The increase in GSH by 
NRF2 activators is not sufficient for protection against H2O2 [24–26].  
 
Figure 6. (A) Compounds involved in the Krebs cycle and (B) common chemical structure of 
neuroprotective KCIs (PA, OAA, and AKG). Note that PA, OAA, and AKG have the common 
chemical structure of the α-keto acid group—indicated by the dotted circle—with which molecules 
can directly react with H2O2. 
5. Conclusions 
This present study importantly suggests that there are 2 distinctive oxidative mechanisms: one 
induced by H2O2 and the other by Glu. α-Ketoacid group-containing KCIs (PA, OAA, and AKG) 
protected the cells against the former but not against the latter, whereas Nrf2 activators act vice versa. 
The central nervous system is particularly vulnerable to oxidative damage due to its high energy 
expenditure and oxygen demand [24–26]. Elevated concentrations of free radicals and resultant 
oxidative damage, such as lipid peroxidation and protein carbonylation, have been repeatedly 
demonstrated in neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, and 
ischemic stroke [24–26]. Thus, PA, OAA, and AKG, being natural metabolic intermediates and energy 
substrates, exert antioxidant effects in the brain and other tissues susceptible to H2O2. 
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Figure 6. (A) Compounds involved in the Krebs cycle and (B) common chemical structure of
neuroprotective KCIs (PA, OAA, and AKG). Note that PA, OAA, and AKG have the common chemical
structure of the α-keto acid group—indicated by the dotted circle—with which molecules can directly
react with H2O2.
Interestingly, the protection afforded by PA, OAA, and AKG was totally different than that
of NRF2 activators such as carnosic acid [19,20], zonarol [21,22], and tert-butyl hydroquinone [23].
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These activators can protect cells against a high concentration of Glu, but not against H2O2. Nrf2
activators protect cells against high Glu concentrations by inhibiting the decrease in GSH by induction
of Phase-2 enzymes, the action of which enhances the production of GSH [24–26]. The increase in GSH
by NRF2 activators is not sufficient for protection against H2O2 [24–26].
5. Conclusions
This present study importantly suggests that there are 2 distinctive oxidative mechanisms: one
induced by H2O2 and the other by Glu. α-Ketoacid group-containing KCIs (PA, OAA, and AKG)
protected the cells against the former but not against the latter, whereas Nrf2 activators act vice versa.
The central nervous system is particularly vulnerable to oxidative damage due to its high energy
expenditure and oxygen demand [24–26]. Elevated concentrations of free radicals and resultant
oxidative damage, such as lipid peroxidation and protein carbonylation, have been repeatedly
demonstrated in neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, and
ischemic stroke [24–26]. Thus, PA, OAA, and AKG, being natural metabolic intermediates and energy
substrates, exert antioxidant effects in the brain and other tissues susceptible to H2O2.
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